Kathleen Neville
Children's Mercy Hospital Kansas City · Children's Mercy Hosptials and Clinics
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kathleen Neville as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:50 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT02139397 · Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory NeuroblastomaGiselle Sholler · completed · Neuroblastoma Recurrent · study chair
- Ph1NCT01506544 · Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell AnemiaChildren's Mercy Hospital Kansas City · completed · Sickle Cell Anemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Pharmacogenetics of Pediatric Sickle Cell DiseaseK23HL077684 · NHLBI · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · fiscal years 2006 to 2010 · $142,012 awarded in 2010Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:50 UTC. The ranking covers the 200 most relevant of 28 PubMed records, and a shared surname and initials can bring in a namesake. All 28 on PubMed
- A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.PLoS One · 2015125 citationsRCR 3.7
- Prevention of hyponatremia during maintenance intravenous fluid administration: a prospective randomized study of fluid type versus fluid rate.J Pediatr · 2010101 citationsRCR 3.9
- Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015).J Clin Oncol · 2004100 citationsRCR 1.9
- 95 citationsRCR 3.4
- Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial.Lancet Haematol · 202286 citationsRCR 8.3
- Isotonic is better than hypotonic saline for intravenous rehydration of children with gastroenteritis: a prospective randomised study.Arch Dis Child · 200685 citationsRCR 3.1
- Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study.Lancet Haematol · 201885 citationsRCR 2.8
- Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).Am J Hematol · 201757 citationsRCR 2.9
- Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy.Am J Hematol · 201555 citationsRCR 2.6
- Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.Am J Hematol · 202052 citationsRCR 3.7